FindMyKOL
Clinical trialNCT01303315TerminatedInterventional

TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy

SponsorMetaCure (USA), Inc.Enrollment20Diabetes Mellitus, Type 2
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To assess the TANTALUS therapy in type 2 diabetic patients who can not tolerate GLP-1 agonist due to unacceptable side effects; and to assess the TANTALUS therapy in type 2 diabetic patients who do not sufficiently benefit from GLP-1 receptor agonist therapy
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Czechia
  • Fakultni Nemocnice U Sv. Anny V Brne

    Brno, Czechia

  • Klinika Gerontologická A Metabolická,

    Hradec Králové, Czechia

  • General University Hospital,

    Prague, Czechia

  • Prednosta Ob Kliniky A.S.,

    Prague, Czechia

Germany
  • Asklepios Klinik St. Georg

    Hamburg, Free and Hanseatic City of Hamburg, Germany

  • Diabetes Zentrum

    Bad Mergentheim, Germany

  • Diabetes-Praxis Muenster

    Münster, Germany

Romania
  • 'N. Paulescu' National Institute of Diabetes, Nutrition and Metabolic Diseases

    Bucharest, Romania

  • Cmi Dr Busegeanu Mihaela Magdalena-Ploiesti

    Bucharest, Romania

  • Fundeni Hospital - Surgical

    Bucharest, Romania

  • Sanatatea Ta Medical Center

    Bucharest, Romania

  • Sf. Ioan Hospital - Surgical

    Bucharest, Romania

  • Spitalul Pelican, Orada

    Bucharest, Romania

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2011
Primary completion
31 Jul 2011
Completion
31 Jul 2011
Last update posted
22 Sept 2016
Registered enrollment
20
Registry id
NCT01303315
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.